Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysis.
about
Differential clinical profile of candesartan compared to other angiotensin receptor blockersFirst Generic ARB Approval Draws a Wave of Comparative Studies.Long-Term Cost-Effectiveness of Upper Airway Stimulation for the Treatment of Obstructive Sleep Apnea: A Model-Based Projection Based on the STAR TrialInfluence of initial angiotensin receptor blockers on treatment persistence in uncomplicated hypertension: A nation-wide population-based study.Cost-effectiveness of renin-guided treatment of hypertension.
P2860
Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Comparative clinical- and cost ...... ta- and cost-utility analysis.
@ast
Comparative clinical- and cost ...... ta- and cost-utility analysis.
@en
type
label
Comparative clinical- and cost ...... ta- and cost-utility analysis.
@ast
Comparative clinical- and cost ...... ta- and cost-utility analysis.
@en
prefLabel
Comparative clinical- and cost ...... ta- and cost-utility analysis.
@ast
Comparative clinical- and cost ...... ta- and cost-utility analysis.
@en
P2093
P2860
P1476
Comparative clinical- and cost ...... ta- and cost-utility analysis.
@en
P2093
A D Hingorani
A M Grosso
P N Bodalia
R J Macallister
P2860
P304
P356
10.1111/J.1742-1241.2011.02633.X
P577
2011-02-01T00:00:00Z